Riskpilot← Back to searchSign inGet full accessmbh Derma Supply ApS
APSActiveCVR 38653288Andkærvej 19DBeauty care and other beauty treatment activities · NACE 9622Est. 20173 employees
Revenue 2025
DKK 3,1M
+9% vs 2024
EBITDA margin
18.5%
+30% vs 2024
Equity ratio
53.5%
Financial strength
Net profit 2025
DKK 448K
+25% vs 2024
| Revenue | DKK 3,1M | +9% |
| EBITDA | DKK 582K | +30% |
| Net profit | DKK 448K | +25% |
| Total assets | DKK 1,2M | +0% |
| Equity | DKK 653K | +12% |
| Employees | 3 | — |
Legal name
mbh Derma Supply ApS
CVR number
38653288
Legal form
Anpartsselskab
NACE code
9622 · Beauty care and other beauty treatment activities
Founded
11. maj 2017
Share capital
DKK 150.000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af to direktører
eller en direktør og formanden for bestyrelsen.
Company purpose
Selskabets formål er at drive handelsvirksomhed samt enhver anden i forbindelse hermed beslægtet virksomhed.
Address
Andkærvej 19D
Phone
+4526171378
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2.294 | 2.732 | 2.820 | 2.886 | 3.148 |
| Staff expenses | -1.707 | -1.853 | -1.926 | -2.439 | -2.566 |
| EBITDA | 612 | 879 | 894 | 446 | 582 |
| Depreciation & amort. | -50 | -50 | -50 | -0 | -0 |
| EBIT | 562 | 829 | 844 | 446 | 582 |
| Net financials | -2 | -3 | -5 | 0 | -3 |
| Profit before tax | 560 | 826 | 839 | 446 | 578 |
| Tax | 124 | 191 | 212 | 89 | 131 |
| Net profit | 436 | 635 | 626 | 358 | 448 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1.475 | 1.393 | 1.666 | 1.224 | 1.220 |
| Equity | 664 | 799 | 825 | 583 | 653 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 811 | 594 | 841 | 641 | 567 |
| Total debt | 811 | 594 | 841 | 641 | 567 |
EBITDA margin
18.5%
This company
15.8%
Market median
+17% vs market
20212025
Equity ratio
53.5%
This company
38.2%
Market median
+40% vs market
20212025
Return on equity
68.6%
This company
18.4%
Market median
+273% vs market
20212025
Net profit margin
14.2%
This company
8.1%
Market median
+75% vs market
20212025
Asset turnover
2.58×
This company
1.12×
Market median
+130% vs market
20212025
Debt / equity
0.87×
This company
0.62×
Market median
+40% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
EB Management | Management | 2020 |
MB Management | Management | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 50–66.65% | 50–66.65% | 2023 | |
| Company | 50–66.65% | 50–66.65% | 2023 | |
| Individual | 33.33–49.99% | 33.33% | 2020 | |
| Company | 33.33–49.99% | 33.33–49.99% | 2020 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MBH-G Holding ApS
mbh Derma Supply ApS Board members of mbh Derma Supply ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Erik Bang Hansen | Management | 0 companies |
| Mette Bang Hansen | Management | 0 companies |
| Mogens Hansen | Chairman | 0 companies |